SCHEMBL7136554

SCHEMBL7136554

COC(=O)c1ccsc1-c1cccc(OCCCCN(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
KDM4E B2RXH2 7/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 2/20 0.48
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
CHEK2 O96017 1/20 0.41
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
ROCK2 O75116 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
ROCK1 Q13464 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076016 0.97 KDM4E (0.49) ALDH1A1MAPTKMT2AKDM4ESMN1; SMN2
SCHEMBL7076583 0.93 KDM4E (0.48) ALDH1A1MAPTKMT2AKDM4ESMN1; SMN2
SCHEMBL7075963 0.89 ALDH1A1 (0.55) ALDH1A1MAPTKMT2AKDM4ESMN1; SMN2
SCHEMBL7074931 0.86 KDM4E (0.44) ALDH1A1MAPTKMT2AKDM4ELMNA
SCHEMBL7130108 0.86 KDM4E (0.43) ALDH1A1MAPTKMT2AKDM4ELMNA
SCHEMBL7076586 0.86 KDM4E (0.49) ALDH1A1MAPTKDM4ESMN1; SMN2THRA
SCHEMBL7076243 0.85 KDM4E (0.54) ALDH1A1MAPTKMT2AKDM4ESMN1; SMN2
SCHEMBL1776033 0.84 KDM4E (0.53) ALDH1A1MAPTKMT2AKDM4ESMN1; SMN2
SCHEMBL7075715 0.84 KDM4E (0.43) ALDH1A1MAPTKMT2AKDM4ELMNA
SCHEMBL7131687 0.81 KDM4E (0.53) ALDH1A1MAPTKMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051368-A1 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-06-26 WO disclosed